Article

The International Society of Bilateral Cataract Surgery holds inaugural meeting during ESCRS

The inaugural meeting of the International Society of Bilateral Cataract Surgeons (ISBCS) was held Sept. 1, during the recent annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS).

Key Points

Berlin-The inaugural meeting of the International Society of Bilateral Cataract Surgeons (ISBCS) was held Sept. 1, during the recent annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS). Cataract surgeons from three continents attended the convocation.

"The ISBCS has a dual focus, namely, to foster interest in simultaneous bilateral cataract surgery and to disseminate peer-reviewed literature on the subject so that ophthalmologists worldwide can be aware of the existence of a reputable body of opinion on the subject," said Charles Claoué, MA, MD, DO, FRCS, FRCOphth, FEBO, MAE.

"The ISBCS also wishes to encourage discussion of simultaneous bilateral cataract surgery and to organize educational meetings for surgeons. The opinion was expressed that ophthalmologists need to revisit this subject and to hear all the arguments in favor of simultaneous bilateral cataract surgery," he said.

Dr. Arshinoff expressed his gratitude to the founding sponsors of the ISBCS, Rayner Intraocular Lenses Ltd., and Advanced Medical Optics for their support and noted that Alcon Laboratories and Carl Zeiss Meditec also had expressed an interest in becoming founding sponsors. During the first meeting, the treasurer confirmed that he would write letters of appreciation to the sponsors and would launch a yearly sponsorship scheme in the new year. It was hoped that future developments would become clear before the next meeting that will occur during the upcoming annual meeting of the American Society of Cataract and Refractive Surgery in San Francisco, where the society hopes to run a course on simultaneous bilateral cataract surgery.

The meeting concluded with Dr. Claoué stating: "We are at the start of history being made; we are going to change the way cataract surgery is practiced."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.